Clinical specificity
Build around the result that matters.
Use available results, numeric values, reference ranges, and longitudinal testing history to define clinically relevant cohorts for your use case.
Turn observed laboratory activity into clinically specific, NPI-level intelligence for the teams and channels you already use.
Understand which HCPs to evaluate, the clinical signal behind their relevance, and how to bring that context into field, CRM, agency, and omnichannel programs.
Conceptual workflow. Available attributes and uses depend on source data and licensed scope.
Specialty alone does not explain an HCP's relevance to your brand. Observed laboratory results and testing history can add clinical specificity to how you define audiences and prioritize engagement.
Use available results, numeric values, reference ranges, and longitudinal testing history to define clinically relevant cohorts for your use case.
Add linked patient and provider context to help identify relevant treating specialists and additional HCPs for further evaluation.
Deliver NPI-level intelligence into your existing commercial environment so it can inform targeting, field prioritization, analytics, and agency execution within the licensed scope.
Available clinical attributes vary by source and assay. Cohort criteria, provider enrichment, delivery, and permitted uses are agreed for each program.
Prognos supplies the lab-derived intelligence. Your teams and partners apply it through the workflows, systems, and engagement strategies that fit your brand.
Use relevant lab activity and provider intelligence to help your team evaluate which HCPs to prioritize and bring context into follow-up.
Start with the clinical question, relevant tests or biomarkers, result criteria, and available patient history. Align the cohort with the decision your team needs to make.
Bring available lab attributes into a consistent structure, resolve overlap, and add linked patient and provider context to improve the usefulness of the signal.
Evaluate the resulting NPIs alongside your target universe, including relevant inclusion or exclusion criteria and the opportunity to identify additional providers.
Agree the delivery format, cadence, and intended workflows. Review provider relevance, use of the intelligence, and program performance with your team.
Average expansion in the actionable NPI universe in a published MAC program.
A specialty biopharma brand combined historical lab profiling with prospective alerts and provider enrichment. The client began without the contributing laboratory source integrated into its baseline data.
Read the published case study ↗Indexed illustration calculated from the published 220% average increase; these are not actual NPI counts. Program-specific results, not a forecast for another brand. Source: public MAC case study, September 23, 2026.
When the laboratory record lists an ordering clinician, pathologist, or facility, your team may need additional context to evaluate the HCPs involved in care.
Prognos Care Team uses linked patient and provider context to help identify relevant treating specialists and reveal additional providers beyond the lab record.
Explore Care Team →Observed provider activity supports evaluation; it does not by itself confirm a disease-specific treating role.
Agree the response window and success measures at the start. Track whether the intelligence reaches the right workflow, whether teams act on it, and what can be evaluated downstream.
Prognos Fusion can bring participating licensed lab sources into a harmonized, enriched feed, including available Care Team context, for your analytics and commercial workflows.
Lab-derived, NPI-level intelligence built around agreed clinical criteria, available source attributes, provider context, and delivery requirements. The program can support HCP targeting, field prioritization, analytics, alerts, and agency or omnichannel workflows.
Prognos can deliver intelligence into your existing agency, CRM, field, analytics, and omnichannel ecosystem. The intended users, channels, delivery requirements, and reuse are defined in the licensed scope.
Cadence is aligned to source availability and the intended workflow. Options can include daily, weekly, monthly, or one-time delivery. A program should distinguish the timing of the underlying lab event, Prognos receipt, and downstream delivery.
Yes. Comparing relevant NPIs with your existing targeting universe can help assess overlap and incremental provider visibility. Inclusion or exclusion criteria and matching requirements should be agreed during program design.
Bring your therapeutic area, a priority test or biomarker, and the workflow you want to support. Let's explore the clinical signal, relevant providers, and delivery approach for your brand.